WHOOP, Field Trip partner to study impact of psychedelic therapies
Category: #health  By Nikita Chaurasia  Date: 2020-11-21
  • share
  • Twitter
  • Facebook
  • LinkedIn

WHOOP, Field Trip partner to study impact of psychedelic therapies

WHOOP Inc., a prominent provider of health tracking and monitoring services, has reportedly announced a partnership with Field Trip Health Ltd., leader in development and delivery of psychedelic therapies. According to reliable sources, Field Trip will use WHOOP’s Strap 3.0 in order to determine biometric effects of its psychedelic therapies on mental and physiology health.

Field Trip reportedly intends to perform an observational study to understand if its ketamine-assisted therapies, which have been proved to be beneficial in treating mental health conditions including PTSD, anxiety, and depression, could improve physical health as well.

It is to be noted that, Field Trip has acquired WHOOP products and has gained access to additional data insights through a research collaboration and enterprise program. The firm is also planning to open Field Trip Health centers across Europe and North America for delivering their psychedelic therapies.

Dr. Ryan Yermus, Chief Clinical Officer at Field Trip, mentioned in a comment that clinical outcomes from their first three centers in Los Angeles, New York, and Toronto, have been overwhelmingly positive, with a substantial decrease in depressive symptoms, trauma-related symptoms, and anxiety.

If reports are to be believed, the research will initially be conducted on military veterans seeking ketamine-assisted therapies via Basecamp program of Field Trip and then expand to the generic public.

Some studies have already proved that physiological metrics such as slow wave sleep patterns and HRV will be improved via psychedelic therapies of Field Trip, sources confirmed. The potential collaboration between the two companies is to better understand the connection between physiology and mental wellbeing.

As per credible sources, WHOOP was recently valued at USD 1.2 billion after receiving over USD 100 million in a Series E funding round. At present, the company's bands are being used in a COVID-19 vaccine trials and have also been used on the LPGA tour to track the health of sports players.

Source Credits- https://www.globenewswire.com/news-release/2020/11/19/2130016/0/en/Field-Trip-Health-Ltd-and-WHOOP-announce-partnership-to-measure-effect-of-psychedelic-therapies-on-physiology-and-mental-health.html

 

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
By Nikita Chaurasia

Israel-based leading provider of advanced solutions for cybersecurity, IoT (Internet of Things) and e-Government sectors Supercom has reportedly signed a supply agreement to deliver its PureSecurity EM (Electronic Monitoring) product suite in Wiscons...

FAA grants approval for mass air shipment of Pfizer’s COVID-19 vaccine
FAA grants approval for mass air shipment of Pfizer’s COVID-19 vaccine
By Nikita Chaurasia

Chicago-headquartered airline company United Airlines Inc. has reportedly started operating charter flights for the distribution of Pfizer Inc.’s COVID-19 vaccine after receiving approval from the Federal Aviation Authority (FAA). For the reco...

Twitter releases plans to relaunch verification program in early 2021
Twitter releases plans to relaunch verification program in early 2021
By Nikita Chaurasia

Twitter Inc. has reportedly planned to relaunch the user verification program as well as a new public application process by 2021. According to reliable sources, the move will allow the American social networking company to address the confusion rega...